Volume 18 - Issue 11 - November, 2006
Feature
Original Contribution
08/01/2008
This paper has prospectively examined the efficacy of the use of bolus glycoprotein IIb/IIIa inhibitor (GPI) during percutaneous coronary intervention (PCI) in a single-arm registry. Both in-hospital outcomes and bleeding complications as...
This paper has prospectively examined the efficacy of the use of bolus glycoprotein IIb/IIIa inhibitor (GPI) during percutaneous coronary intervention (PCI) in a single-arm registry. Both in-hospital outcomes and bleeding complications as...
This paper has prospectively...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
The underlying pathobiology in most patients with acute coronary syndromes (ACS) is culprit lesion disruption with associated thrombosis.1 There is an increasing body of evidence showing that these culprit lesions, the so-called “vulnerable”...
The underlying pathobiology in most patients with acute coronary syndromes (ACS) is culprit lesion disruption with associated thrombosis.1 There is an increasing body of evidence showing that these culprit lesions, the so-called “vulnerable”...
The underlying pathobiology in...
08/01/2008
Journal of Invasive Cardiology